000 | 01344 a2200397 4500 | ||
---|---|---|---|
005 | 20250512234017.0 | ||
264 | 0 | _c19830415 | |
008 | 198304s 0 0 eng d | ||
022 | _a0361-5960 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCobb, W R | |
245 | 0 | 0 |
_aActivity of two phase I drugs, homoharringtonine and tricyclic nucleotide, against surgical explants of human tumors in the 6-day subrenal capsule assay. _h[electronic resource] |
260 |
_bCancer treatment reports _cFeb 1983 |
||
300 |
_a173-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAcenaphthenes |
650 | 0 | 4 |
_aAlkaloids _xtherapeutic use |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aDrug Evaluation, Preclinical _xmethods |
650 | 0 | 4 | _aEvaluation Studies as Topic |
650 | 0 | 4 |
_aHarringtonines _xtherapeutic use |
650 | 0 | 4 | _aHomoharringtonine |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aKidney |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aNeoplasm Transplantation |
650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
650 | 0 | 4 |
_aRibonucleotides _xtherapeutic use |
700 | 1 | _aBogden, A E | |
700 | 1 | _aReich, S D | |
700 | 1 | _aGriffin, T W | |
700 | 1 | _aKelton, D E | |
700 | 1 | _aLePage, D J | |
773 | 0 |
_tCancer treatment reports _gvol. 67 _gno. 2 _gp. 173-8 |
|
999 |
_c6824860 _d6824860 |